| Mia Valbracht, CRNA, DNP | |
|
1 Medical Center Dr, Biddeford, ME 04005-9422 | |
| (207) 283-7042 | |
| Not Available |
| Full Name | Mia Valbracht |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 8 Years |
| Location | 1 Medical Center Dr, Biddeford, Maine |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1952753766 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Southern Maine Health Care | Biddeford, ME | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mainehealth | 7517860588 | 2067 |
News Archive
Two existing chemotherapy drugs appear to be a powerful pair in targeting errant stem cells that are making breast cancer and enabling its spread and recurrence, scientists report.
Researchers at McMaster University's Stem Cell and Cancer Research Institute have made significant steps forward in understanding the stem cells of the human blood system after discovering how a key protein allows for better control and regeneration of these cells.
A new study led by Indiana University-Purdue University Indianapolis assistant professor of psychology Tamika Zapolski has found differing risks for binge drinking based on race, income and age.
NPS Pharmaceuticals, a specialty pharmaceutical company developing innovative therapeutics for rare gastrointestinal and endocrine disorders, today announced the completion of patient randomization in its Phase 3 registration study of GATTEX® (teduglutide). The double-blind, placebo-controlled safety and efficacy study, which is known as STEPS, is being conducted in patients with parenteral nutrition (PN) dependent short bowel syndrome (SBS) and is now fully randomized with 86 patients.
› Verified 5 days ago
| Entity Name | Mainehealth |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790265502 PECOS PAC ID: 7517860588 Enrollment ID: O20040701000166 |
News Archive
Two existing chemotherapy drugs appear to be a powerful pair in targeting errant stem cells that are making breast cancer and enabling its spread and recurrence, scientists report.
Researchers at McMaster University's Stem Cell and Cancer Research Institute have made significant steps forward in understanding the stem cells of the human blood system after discovering how a key protein allows for better control and regeneration of these cells.
A new study led by Indiana University-Purdue University Indianapolis assistant professor of psychology Tamika Zapolski has found differing risks for binge drinking based on race, income and age.
NPS Pharmaceuticals, a specialty pharmaceutical company developing innovative therapeutics for rare gastrointestinal and endocrine disorders, today announced the completion of patient randomization in its Phase 3 registration study of GATTEX® (teduglutide). The double-blind, placebo-controlled safety and efficacy study, which is known as STEPS, is being conducted in patients with parenteral nutrition (PN) dependent short bowel syndrome (SBS) and is now fully randomized with 86 patients.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mia Valbracht, CRNA, DNP 2921 Annunciation St, New Orleans, LA 70115-1003 Ph: () - | Mia Valbracht, CRNA, DNP 1 Medical Center Dr, Biddeford, ME 04005-9422 Ph: (207) 283-7042 |
News Archive
Two existing chemotherapy drugs appear to be a powerful pair in targeting errant stem cells that are making breast cancer and enabling its spread and recurrence, scientists report.
Researchers at McMaster University's Stem Cell and Cancer Research Institute have made significant steps forward in understanding the stem cells of the human blood system after discovering how a key protein allows for better control and regeneration of these cells.
A new study led by Indiana University-Purdue University Indianapolis assistant professor of psychology Tamika Zapolski has found differing risks for binge drinking based on race, income and age.
NPS Pharmaceuticals, a specialty pharmaceutical company developing innovative therapeutics for rare gastrointestinal and endocrine disorders, today announced the completion of patient randomization in its Phase 3 registration study of GATTEX® (teduglutide). The double-blind, placebo-controlled safety and efficacy study, which is known as STEPS, is being conducted in patients with parenteral nutrition (PN) dependent short bowel syndrome (SBS) and is now fully randomized with 86 patients.
› Verified 5 days ago
Jaclyn Elizabeth Masters, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 1 Medical Center Dr, Biddeford, ME 04005 Phone: 207-283-7000 | |
Melani M Pene, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 1 Medical Center Dr, Biddeford, ME 04005 Phone: 207-283-7040 Fax: 207-283-7850 | |
Nancy A Quint, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Dr, Biddeford, ME 04005 Phone: 207-283-7040 Fax: 207-283-7850 | |
Brendan Patrick Ryan, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Dr, Biddeford, ME 04005 Phone: 207-283-7000 | |
Boyd A Phillips, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 1 Medical Center Dr, Biddeford, ME 04005 Phone: 207-283-7040 Fax: 207-283-7850 | |
Lora Leigh Manning, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 1 Medical Center Dr, Biddeford, ME 04005 Phone: 207-283-7040 Fax: 207-283-7850 | |
Robert J. Vieto Jr., MSNA, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Dr, Biddeford, ME 04005 Phone: 207-283-7000 |